1 To test the feasibility of administering antibiotics by subcutaneous infusion to the elderly, we compared the pharmacokinetics of tobramycin (single dose of 80 mg) given by hypodermoclysis (HDC) with the kinetics of the antibiotic injected intravenously (i.v.) in 10 young (<50 years old) and 10 elderly (>65 years old) healthy volunteers. Similar studies were performed with ampicillin (single dose of 1 g) in 12 young and 10 older healthy volunteers. 2 Compared with the i.v. route, HDC delayed the time to reach the maximal plasma concentration (t max ) of tobramycin in young volunteers: 32±6 (s.d.) min vs 88±46, P<0.005, and older volunteers: 27±4 min vs 89±15, P<0.005. Administration of the antibiotics by HDC was well tolerated. The plasma concentration of tobramycin 30 min after the end of infusion (C 60 ) was lower (P<0.05) following HDC than after the i.v. route in both young, 2.2±0.7 vs 3.5±0.8 mg ml−1, and elderly subjects, 2.2±0.8 vs 3.8±0.9. mg ml−1. 3 The area under the curve (AUC) of tobramycin given by HDC was slightly smaller than when given i.v., i.e. in young subjects: 740±225 (s.d.) vs 893±223 mg ml−1 min, NS, and in the elderly: 980±228 vs 1056±315 mg ml−1 min, NS. 4 When ampicillin was administered by HDC, the t max was also delayed in young volunteers: 45±18 vs 23±6 min, and in the elderly: 49±18 vs 27±4 min, P<0.005, the AUC was greater by HDC than i.v. in the young volunteers: 4527±1658 mg ml−1 min vs 3810±1033 mg ml−1 min and in the elderly: 6795±2094 mg ml−1 min vs 4217±1518 mg ml−1 min, and the C 60 was higher by HDC in the young: 27±7 vs 24±9 mg ml−1, and in the elderly: 32±9 vs 23±11 mg ml−1, P<0.05. 5 In conclusion, HDC delays the entry of the antibiotic into the systemic circulation, but did not affect the amount available. HDC was well tolerated and could become an adequate method for antibiotic administration to the elderly.
Introduction
Hypodermoclysis (HDC), the subcutaneous infusion of a solution using hyaluronidase to enhance its diffusion, was introduced about 50 years ago [1] [2] [3] [4] [5] [6] [7] [8] [9] . It became Moderate infections in elderly patients living in chronic care institutions may require the administration of obsolete with the development of i.v. catheters but is still employed for geriatric and palliative care rehyantibiotics through an intravenous (i.v.) route and such treatment may compel their transfer to hospitals. dration when the access to veins is complicated [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Some drugs have been successfully administered by participated in the pharmacokinetic study. All subjects were healthy, as judged by a normal physical examin-HDC [ 10, 15, 17, 20] , but HDC is seldom used for drug therapy and has not yet been recommended ation and normal routine blood tests including serum creatinine. None was known to be hypersensitive to the officially.
Antibiotics given by this route could reduce the antibiotics and a pretest ruled out hypersensitivity to hyaluronidase. A subgroup of young (n=12) and elderly number of patients being transferred from chronic care institutions to hospitals. However, the efficacy and volunteers (n=10) participated in the ampicillin arm of the pharmacokinetic study, while another subgroup of toxicity of antibiotic delivered by HDC have not been sufficiently documented. The present studies were young (n=10) and the same elderly subjects (n=10) participated in the tobramycin arm. Five young healthy designed to assess the usefulness of HDC for the administration of ampicillin, a beta-lactam antibiotic, volunteers participated in both arms of this study. Within each antibiotic subgroup, all subjects, whether and tobramycin, an aminoglycoside. Firstly, the local toxicity of the antibiotics administered by HDC was young or old, received a dose of the antibiotic through the i.v. route and the same dose by HDC, after a 1 week assessed in young healthy volunteers. Secondly, the pharmacokinetics of a single dose of ampicillin and interval. The order of administration (i.v. vs HDC) was not randomized. With both routes, the dose of ampicillin tobramycin were documented in young and elderly healthy volunteers administered by HDC in comparison used was 1 g for all individuals, and the dose of tobramycin was 80 mg. The antibiotics were diluted in to the i.v. route. 50 ml of NaCl 0.9% and infused i.v. over a 30 min period, and by HDC over a 20 min period. For HDC, 75 units of hyaluronidase were mixed with the antibiotic solution and another 75 units were injected subcutaneMethods ously at the catheter site. Local toxicity was monitored in all cases. Blood samples for the determination of The protocol was approved by the Centre de Recherche Hô tel-Dieu de Montréal's ethics committee. All subjects serum antibiotic concentrations were drawn at 0, 10, 15, 20, 25, 30, 35, 40, 45, 60, 90, 120, 150, 210, 270, 330 and gave written informed consent after full explanation of the experimental procedure.
390 min for the i.v. route, and at 0, 10, 20, 22.5, 25, 30, 45, 60, 90, 120, 150, 210, 270, 330 and 390 min for HDC. Time 0 corresponds to the beginning of infusion. Time 60 min (30 min following the end of infusion) was T oxicity study specifically taken into account since it corresponds to a clinically relevant parameter approximating the time of Local toxicity was examined in 16 healthy volunteers following the HDC administration of either ampicillin peak concentration for the adjustment of aminoglycoside dosage. Blood samples were immediately centrifuged at or tobramycin. All subjects were younger than 40 years of age, and had no history of hypersensitivity to either 4°C and plasma samples were frozen at −20°C in the case of tobramycin, until analysis, but in the case of antibiotic. All subjects were healthy, as judged by a normal physical examination and normal routine blood ampicillin, plasma samples were assayed on the same day without prior freezing. tests including serum creatinine. Preliminary tests showed no hypersensitivity to hyaluronidase before the beginning of infusion. Each volunteer was then infused 50 ml of NaCl 0.9% containing 75 units of hyaluronidase Analytical methods for 30 min in both thighs. The solution infused subcutaneously in the left thigh with a butterfly catheter Plasma ampicillin was measured by biological assay: a standard curve was drawn for the inhibition of Sarcina contained 0.5 g of ampicillin or 40 mg of tobramycin. Standard doses of 1 g of ampicillin and 80 mg of lutea (ATCC 9341 ) growth. Blood samples from patients given ampicillin were then tested for inhibition of this tobramycin were not used in this pilot toxicity study. In addition, 75 units of hyaluronidase were injected bacteria [21 ] . Plasma tobramycin was measured by immunoenzymatic assay (EMITB, Syva Corporation, subcutaneously at the catheter insertion site on both thighs. Those two separate 75-unit doses of hyaluroniPalo Alto, CA, USA) [ 22] . dase are used regularly for hypodermoclysis in an affiliated chronic care hospital. Frequent inspections were undertaken for local signs of pain, warmth, swelling Pharmacokinetic analysis and redness of the skin where the catheter was introduced. All subjects were evaluated for 3 h and Maximum serum concentration of the antibiotics (C max ) was established by visual inspection of serum concenduring this time, they used a visual analogue scale to describe the pain they felt.
tration vs time curve. The time required to reach this maximum serum concentration was defined as t max . The elimination rate constant (l z ) was calculated by linear regression of the terminal phase of plasma concenPharmacokinetic study trations until the last measurable concentration (C min ). The area under the concentration vs time curve (AUC) A group of 17 volunteers aged between 17 and 50 years and a second group of 10 volunteers aged over 60 years was calculated by the linear trapezoidal method up to the last measurable serum concentration to which was HDC as a function of time rose much more slowly than with the i.v. infusion (Figures 1 to 4) . As a consequence, added the value of the C min /l z ratio. The subcutaneous infusion of both antibiotics was generally well tolerated. None of the subjects reported any pain on the visual analogue scale with the use of tobramycin, and only one of the eight subjects given ampicillin had a light pain which lasted for 25 min after infusion. Warmth and erythema were found locally with both ampicillin (three subjects) and tobramycin (one subject) as well as with the vehicle alone (two subjects).
Pharmacokinetic study
As shown in Table 1 , the young volunteers were taller, had a similar body weight and higher BSA than the elderly subjects and, as expected, higher creatinine clearance. Antibiotic infusion during the pharmacokinetic study was well tolerated (no pain) in all subjects. In the tobramycin arm, technical problems occurred administered i.v. This observation was independent of the age. In addition, in the elderly, the tobramycin elimination rate constant was smaller than in young volunteers in both route of administration (Table 3 ) . Consequently, the estimated half-life of tobramycin was longer when the antibiotic was administered by HDC than by i.v. On the other hand, the elimination rate constant and the terminal half-life in older subjects was smaller than in young volunteers. Systemic clearance of tobramycin was smaller in older subjects than in young volunteers in both route of administration. Relative bioavailability, AUC HDC /AUC i.v. , or F, was 0.92±0.36 and 0.96±0.16 in young and older subjects respectively (NS). Tobramycin volume of distribution was larger in older subjects than in the young volunteers when the antibiotic was administered i.v.; this difference was not so apparent (P >0.005) in young volunteers (Table 3 ) . The kinetics of ampicillin and of tobramycin infused intravenously to healthy young or elderly volunteers are in perfect agreement with the data published in the literature [23 ] . As expected, because of a reduced renal function in the elderly, the apparent clearance of ampicillin and of tobramycin were lower than the values estimated in the young volunteers.
The results of the present study show that antibiotics administered by HDC enter the systemic circulation more slowly than when administered by i.v. infusion, as reflected by a lower C max and a longer t max in young and elderly subjects. It is to be expected that the administration of hydrosoluble and large molecules by HDC will reduce the rate of absorption, since to be absorbed the drugs must cross cell membranes. It is interesting to note that age did not influence the rate of absorption of a drug administered by HDC. Administration of ampicillin or tobramycin by HDC over clearance i.v.
. In both young and elderly volunteers, the AUC of ampicillin administered by HDC was greater than that occurred at a longer t max than when administered i.v. These differences were independent of age (Tables 2 estimated after the administration of ampicillin i.v. Ampicillin plasma concentrations were assayed by and 3).
The elimination rate constant of ampicillin decreased bioassay, and ageing bacteria may jeopardize the stability of the method. However, the assay was very in young and older subjects receiving the antibiotic by HDC, and terminal half-life was significantly prolonged reproducible over a 21-day period. The increase in ampicillin AUC following the HDC administration does following HDC. In addition, in the elderly, the elimination rate constant of ampicillin administered by HDC not appear to be dependent of the route since the administration of tobramycin by HDC did not yield an or by i.v. was smaller than in young volunteers with a reciprocal prolongation of the terminal half-life. On the AUC greater than that estimated when tobramycin was injected i.v. An increase in AUC may be secondary to other hand, the AUC of ampicillin administered by HDC was greater than when ampicillin was infused i.v an increase in amount absorbed or a decrease in the rate of elimination. Whenever intravenous adminstration in older subjects; in young subjects, the AUC of ampicillin was not significantly affected by the route of yields a 100% bioavailability, the administration by another route could not increase the bioavailability. administration (Table 2) .
When tobramycin was given by HDC, the elimination Therefore, we must conclude that HDC administration of ampicillin decreases its clearance. Ampicillin is rate constant was smaller than when the antibiotic was Table 2 Pharmacokinetic parameters of ampicillin (mean±s.d.) in part due to a decrease of #10% in clearance and an other drugs. Further studies are warranted to assess the safety of hyaluronidase, and to define precisely with increase in its volume of distribution by #27%. In the elderly, the 25% increment in half-life appears to be the optimal dosage regimen to administer ampicillin or tobramycin. net result between a decrease in both its clearance by #40% and its volume of distribution by #20%. Concerning tobramycin, in both young and elderly, the following HDC is peculiar, i.e. the absorption of both 645-649. antibiotics is initially rapid, producing a quick raise in changes, needs to be tested in future study. In young 9 Sund RB, Schou J. Hyaluronidase as an accelerator of subjects, the coefficient of variation usually increased muscular absorption of water and water-soluble compounds. Acta Pharmacol T oxicol 1965; 23: 194-204. when the antibiotic was given by HDC. 
